These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23019580)

  • 21. Antisense cyclic adenosine 5'-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus.
    Tenbrock K; Juang YT; Gourley MF; Nambiar MP; Tsokos GC
    J Immunol; 2002 Oct; 169(8):4147-52. PubMed ID: 12370343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications.
    Liu Y; Liao J; Zhao M; Wu H; Yung S; Chan TM; Yoshimura A; Lu Q
    Eur J Immunol; 2015 Sep; 45(9):2683-93. PubMed ID: 26079624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc deficiency leads to reduced interleukin-2 production by active gene silencing due to enhanced CREMα expression in T cells.
    Kloubert V; Wessels I; Wolf J; Blaabjerg K; Janssens V; Hapala J; Wagner W; Rink L
    Clin Nutr; 2021 May; 40(5):3263-3278. PubMed ID: 33183881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP Response Element Modulator-α Suppresses PD-1 Expression and Promotes Effector CD4
    Hofmann SR; Carlsson E; Kapplusch F; Carvalho AL; Liloglou T; Schulze F; Abraham S; Northey S; Russ S; Surace AEA; Yoshida N; Tsokos GC; Hedrich CM
    J Immunol; 2021 Jul; 207(1):55-64. PubMed ID: 34135066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cyclic AMP response element modulator {alpha} suppresses CD86 expression and APC function.
    Ahlmann M; Varga G; Sturm K; Lippe R; Benedyk K; Viemann D; Scholzen T; Ehrchen J; Müller FU; Seidl M; Matus M; Tsokos GC; Roth J; Tenbrock K
    J Immunol; 2009 Apr; 182(7):4167-74. PubMed ID: 19299714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.
    Sunahori K; Juang YT; Kyttaris VC; Tsokos GC
    J Immunol; 2011 Apr; 186(7):4508-17. PubMed ID: 21346232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1.
    Pan W; Zhu S; Yuan M; Cui H; Wang L; Luo X; Li J; Zhou H; Tang Y; Shen N
    J Immunol; 2010 Jun; 184(12):6773-81. PubMed ID: 20483747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.
    Zhao M; Wang J; Liao W; Li D; Li M; Wu H; Zhang Y; Gershwin ME; Lu Q
    J Autoimmun; 2016 May; 69():64-73. PubMed ID: 26984631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of DNA methylation dictates Cd4 expression during the development of helper and cytotoxic T cell lineages.
    Sellars M; Huh JR; Day K; Issuree PD; Galan C; Gobeil S; Absher D; Green MR; Littman DR
    Nat Immunol; 2015 Jul; 16(7):746-54. PubMed ID: 26030024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease.
    Kuttkat N; Mohs A; Ohl K; Hooiveld G; Longerich T; Tenbrock K; Cubero FJ; Trautwein C
    Gut; 2017 May; 66(5):908-919. PubMed ID: 27686093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations.
    Absher DM; Li X; Waite LL; Gibson A; Roberts K; Edberg J; Chatham WW; Kimberly RP
    PLoS Genet; 2013; 9(8):e1003678. PubMed ID: 23950730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased CD4
    Ahlén Bergman E; Hartana CA; Johansson M; Linton LB; Berglund S; Hyllienmark M; Lundgren C; Holmström B; Palmqvist K; Hansson J; Alamdari F; Huge Y; Aljabery F; Riklund K; Winerdal ME; Krantz D; Zirakzadeh AA; Marits P; Sjöholm LK; Sherif A; Winqvist O
    Clin Epigenetics; 2018 Aug; 10(1):102. PubMed ID: 30075815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of IL-2 in health and autoimmunity.
    Crispín JC; Tsokos GC
    Autoimmun Rev; 2009 Jan; 8(3):190-5. PubMed ID: 18723131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of CREM in systemic lupus erythematosus.
    Xu WD; Zhang YJ; Wang W; Li R; Pan HF; Ye DQ
    Cell Immunol; 2012; 276(1-2):10-5. PubMed ID: 22560675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CREMα overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity.
    Lippe R; Ohl K; Varga G; Rauen T; Crispin JC; Juang YT; Kuerten S; Tacke F; Wolf M; Roebrock K; Vogl T; Verjans E; Honke N; Ehrchen J; Foell D; Skryabin B; Wagner N; Tsokos GC; Roth J; Tenbrock K
    J Mol Cell Biol; 2012 Apr; 4(2):121-3. PubMed ID: 22355096
    [No Abstract]   [Full Text] [Related]  

  • 37. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAMP response element modulator a expression in patients with systemic lupus erythematosus.
    Kyttaris VC; Wang Y; Juang YT; Weinstein A; Tsokos GC
    Lupus; 2006; 15(12):840-4. PubMed ID: 17211988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus.
    Katsiari CG; Tsokos GC
    Autoimmun Rev; 2006 Feb; 5(2):118-21. PubMed ID: 16431340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.
    Gómez-Martín D; Díaz-Zamudio M; Crispín JC; Alcocer-Varela J
    Autoimmun Rev; 2009 Sep; 9(1):34-9. PubMed ID: 19269352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.